DK112521B - Fremgangsmåde til fremstilling af 3'-oxo-4'-hydroxy-cyclopenteno-(1',2'-16,17)-steroider af andorstankrækken eller 4'-estere eller 4'-ethere deraf. - Google Patents

Fremgangsmåde til fremstilling af 3'-oxo-4'-hydroxy-cyclopenteno-(1',2'-16,17)-steroider af andorstankrækken eller 4'-estere eller 4'-ethere deraf.

Info

Publication number
DK112521B
DK112521B DK152664AA DK152664A DK112521B DK 112521 B DK112521 B DK 112521B DK 152664A A DK152664A A DK 152664AA DK 152664 A DK152664 A DK 152664A DK 112521 B DK112521 B DK 112521B
Authority
DK
Denmark
Prior art keywords
andorstane
cyclopenteno
steroids
oxo
ethers
Prior art date
Application number
DK152664AA
Other languages
Danish (da)
English (en)
Inventor
E Ag Merck
Original Assignee
E Ag Merck
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DEM56328A external-priority patent/DE1214225B/de
Application filed by E Ag Merck filed Critical E Ag Merck
Publication of DK112521B publication Critical patent/DK112521B/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
DK152664AA 1963-04-01 1964-03-25 Fremgangsmåde til fremstilling af 3'-oxo-4'-hydroxy-cyclopenteno-(1',2'-16,17)-steroider af andorstankrækken eller 4'-estere eller 4'-ethere deraf. DK112521B (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEM56328A DE1214225B (de) 1963-04-01 1963-04-01 Verfahren zur Herstellung neuer Steroide
DED0056328 1963-04-01

Publications (1)

Publication Number Publication Date
DK112521B true DK112521B (da) 1968-12-23

Family

ID=25972632

Family Applications (1)

Application Number Title Priority Date Filing Date
DK152664AA DK112521B (da) 1963-04-01 1964-03-25 Fremgangsmåde til fremstilling af 3'-oxo-4'-hydroxy-cyclopenteno-(1',2'-16,17)-steroider af andorstankrækken eller 4'-estere eller 4'-ethere deraf.

Country Status (8)

Country Link
US (1) US3290214A (de)
BE (1) BE645738A (de)
CH (1) CH444150A (de)
DK (1) DK112521B (de)
FR (1) FR3329M (de)
GB (1) GB993458A (de)
NL (1) NL6402401A (de)
SE (1) SE311155B (de)

Also Published As

Publication number Publication date
FR3329M (fr) 1965-05-24
US3290214A (en) 1966-12-06
CH444150A (de) 1967-09-30
SE311155B (de) 1969-06-02
NL6402401A (de) 1964-10-02
GB993458A (en) 1965-05-26
BE645738A (de) 1964-09-28

Similar Documents

Publication Publication Date Title
DK116205B (da) Analogifremgangsmåde til fremstilling af 17α-alkanoyloxy-9α-halogen-16β-methyl-11β,21-dihydroxy-Δ<1,4>-pregnadien-3,20-dioner.
DK106552C (da) Fremgangsmåde til fremstilling af substituerede 6,7-benzomorphaner.
DK117957B (da) Fremgangsmåde til fremstilling af 13β-alkyl-3-oxogona-4,9,11-triener.
DK117000B (da) Fremgangsmåde til fremstilling af substituerede phenylamino-1,3-diazacyclopentener-(2) eller syreadditionssalte heraf.
DK104844C (da) Fremgangsmåde til fremstilling af 11,17-bis-oxygenerede-20-ketopregnan-21-glucuronider eller salte heraf.
DK119107B (da) Fremgangsmåde til fremstilling af 11β-hydroperoxy-3-oxo-13-alkyl-Δ<4,9>-gonadiener.
DK121120B (da) Fremgangsmåde til fremstilling af 3-hydroxy-Δ<1,5>-androstadiener eller 3-estere eller 3-ethere deraf.
DK119010B (da) Fremgangsmåde til fremstilling af 1,3-dihydro-5-aryl-2H-1,4-benzodiazepin-2-on-4-oxider eller tilsvarende deoxyforbindelser.
DK115537B (da) Fremgangsmåde til fremstilling af 6-methyl-Δ<8,9>-ergolen-8-carboxylsyre eller lysergsyre.
DK112521B (da) Fremgangsmåde til fremstilling af 3'-oxo-4'-hydroxy-cyclopenteno-(1',2'-16,17)-steroider af andorstankrækken eller 4'-estere eller 4'-ethere deraf.
DK107742C (da) Fremgangsmåde til fremstilling af 1β-hydroxy-5-oxo-4-(2'-carboxyethyl)-7aβ-methyl-5,6,7,7a-tetrahydroindan eller estere deraf.
DK106329C (da) Fremgangsmåde til fremstilling af 3,20-dioxo-19-nor-4,9,11-pregnatrien.
DK105065C (da) Fremgangsmåde til fremstilling af 16α,17α-acetaler eller -ketaler af 3-oxo-16α,17α-dihydroxy-19-nor-4-pregnener eller 3-oxo-16α,17α-dihydroxy-19-nor-5(10)-pregnener.
DK109895C (da) Fremgangsmåde til fremstilling af 1,3-dioxo-2-alkyl-cyclopentaner.
DK114904B (da) Fremgangsmåde til fremstilling af 3,5-diiodthyroniner.
DK109145C (da) Fremgangsmåde til fremstilling af 3,5-dioxo-1,2,4-triazolidiner eller salte deraf.
DK108919C (da) Fremgangsmåde til fremstilling af 1,2-diaryl-4-alkyl-3,5-dioxo-pyrazolidiner eller salte deraf.
DK108211C (da) Fremgangsmåde til fremstilling af Δ<4,9>-estradien-3β,17-dioler eller 3-monoestere, 17-monoestere eller 3,17-diestere heraf.
DK104170C (da) Fremgangsmåde til fremstilling af 3-alkoxy- eller 3-aralkoxy-16-amino-Δ<3,5>-pregnadien-17α-ol-20-oner, eller 16-amino-Δ<4>-pregnen-17α-ol-3,20-dioner.
DK114827B (da) Fremgangsmåde til fremstilling af 5-keto-11-hydroxy-17β-acyloxy-Δ<9>-des-A-estren eller 5,11-diketo-17β-acyloxy-Δ<9>-des-A-estren.
DK112381B (da) Fremgangsmåde til fremstilling af 16-fluormethylen-17α-hydroxy-20-keto-steroider af pregnan-, 19-nor-pregnan- eller iso-pregnanrækken eller 17α-estere deraf.
DK105920C (da) Fremgangsmåde til fremstilling af 3-β-hydroxyethylimino-17 α-acyloxy-20-keto-4,6-pregnadien-(eller 1,4,6-pregnatrien)-derivater.
DK103239C (da) Fremgangsmåde til fremstilling af 2,3-dicyan-1,4-dithia-anthrahydroquinon eller 2,3-dicyan-1,4-dithia-anthraquinon.
DK118400B (da) Fremgangsmåde til fremstilling af Δ<14>-3,20-diketo-21-acyloxy-5β-pregnener eller Δ<4,14>-3,20-diketo-21-acyloxy-pregnadiener.
DK100421C (da) Fremgangsmåde til fremstilling af 3,11,20-triketo-6-fluor-16α-methyl-21-hydroxy-Δ<4>-pregnen eller 21-estere deraf.